WILL
BE LAUNCHED SOON!!!
The
PCR
kit is designed for qualitative
detection of the BCR/ABL fusion gene,which
is the result of a reciprocal translocation between chromosomes 9
and 22,
by the real-time Polymerase Chain Reaction (PCR) method.
Detection
of the three most frequent
variants: Major (Mbcr),
minor (mbcr)
and micro (µbcr)
BCR/ABL. The kit is designed for in
vitro diagnostics and
provides qualitative detection.
The
PCR
kit is designed for the BCR/ABL
p190 fusion gene transcript quantification in bone marrow or peripheral
blood
samples by the real time Polymerase Chain Reaction (PCR) method.
The
BCR/ABL gene transformation (the
so-called Philadelphia chromosome) is the result of a reciprocal
translocation
between chromosomes 9 and 22 and it tends to be primarily diagnosed in
patient
with acute lymphoblastic leukemia (ALL). The test is suitable for
establishing
the patient's molecular response level to the applied treatment, for
monitoring
minimum residues of the disease in the long run and for predicting
possible
relapses. The kit is designed for in vitro
diagnostics.
The
PCR kit is designed for the BCR/ABL
p210 fusion gene transcript quantification in bone marrow or peripheral
blood
samples by the real time Polymerase Chain Reaction (PCR) method.
The
BCR/ABL gene transformation (the
so-called Philadelphia chromosome) is the result of a reciprocal
translocation
between chromosomes 9 and 22 and it tends to be primarily diagnosed in
patient
with chronic myeloid leukemia (CML) and acute lymphoblastic leukemia
(ALL). The
test is suitable for establishing the patient's molecular response
level to the
applied treatment, for monitoring minimum residues of the disease in
the long
run and for predicting possible relapses. The kit is designed
for in vitro diagnostics.
|